Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating women with metastatic breast cancer.
Key facts
- Study ID
- NCT00002585
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 20
- Starts
- 1994-02-01
- Expected to finish
- 2001-01-01
- Last updated by the study team
- 2012-03-12
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.